Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol

An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroendocrinology 2019-12, Vol.31 (12), p.e12809-n/a
Hauptverfasser: Domínguez‐Ordóñez, Raymundo, García‐Juárez, Marcos, Lima‐Hernández, Francisco J., Gómora‐Arrati, Porfirio, Domínguez‐Salazar, Emilio, Luna‐Hernández, Ailyn, Hoffman, Kurt L., Blaustein, Jeffrey D., Etgen, Anne M., González‐Flores, Oscar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 12
container_start_page e12809
container_title Journal of neuroendocrinology
container_volume 31
creator Domínguez‐Ordóñez, Raymundo
García‐Juárez, Marcos
Lima‐Hernández, Francisco J.
Gómora‐Arrati, Porfirio
Domínguez‐Salazar, Emilio
Luna‐Hernández, Ailyn
Hoffman, Kurt L.
Blaustein, Jeffrey D.
Etgen, Anne M.
González‐Flores, Oscar
description An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.
doi_str_mv 10.1111/jne.12809
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2330478514</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2330478514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</originalsourceid><addsrcrecordid>eNp1kMtOxCAUhonR6HhZ-AKGxJWLKpTSlqUxXmPUhfuGgUPKyJQRqKYP4vuKjrqTxTkEvnx_8iN0SMkpzedsMcApLVsiNtCMspoXZVvWm2hGBGdFS0W1g3ZjXBBCG87INtphtKGcMDpDH0_BJ7ADfrGDjIDt0Nu5TT7EfDVjBJ13CvIN8rRqdDK4Cfvw9epx6gF___glaCsd7qeVT710cjlGPHdeveDY-5CwkwkGNWEjlXU2yWT9gL3Bzgfto81wtkLMSdp6t4-2jHQRDn72Hnq-uny-uCnuH69vL87vC8U4EwWbtyCYIJw0Zavaqqrz0LUABYyatjQ1Z0bVlYSyLoFXSnMlK60FN40WhO2h47V2FfzrmNO7hR_DkBO7kjFSNS2nVaZO1pQKPsYAplsFu5Rh6ijpvvrvcv_dd_-ZPfoxjvNcyR_5W3gGztbAu3Uw_W_q7h4u18pPVASTlA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2330478514</pqid></control><display><type>article</type><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</creator><creatorcontrib>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</creatorcontrib><description>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</description><identifier>ISSN: 0953-8194</identifier><identifier>EISSN: 1365-2826</identifier><identifier>DOI: 10.1111/jne.12809</identifier><identifier>PMID: 31715031</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Animals ; Carbazoles - pharmacology ; Cyclic AMP - analogs &amp; derivatives ; Cyclic AMP - pharmacology ; Estradiol - physiology ; Estrogen Antagonists - pharmacology ; Female ; Flavonoids - pharmacology ; Hypothalamus (ventromedial) ; Infusions, Intraventricular ; Kinases ; Latency ; Lordosis - chemically induced ; Lordosis - physiopathology ; lordosis behaviour ; Male ; MAP kinase ; Microinjections ; mitogen‐activated protein kinase ; oestradiol ; Protein kinase A ; Protein kinase G ; protein kinase inhibitor ; Protein kinase inhibitors ; Protein Kinase Inhibitors - administration &amp; dosage ; Protein Kinase Inhibitors - pharmacology ; Proteins ; Pyrimidines - pharmacology ; Rats ; Src protein ; Src tyrosine kinase ; Thionucleotides - pharmacology ; Ventromedial Hypothalamic Nucleus - drug effects ; Ventromedial Hypothalamic Nucleus - physiology</subject><ispartof>Journal of neuroendocrinology, 2019-12, Vol.31 (12), p.e12809-n/a</ispartof><rights>2019 British Society for Neuroendocrinology</rights><rights>2019 British Society for Neuroendocrinology.</rights><rights>Copyright © 2019 British Society for Neuroendocrinology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</citedby><cites>FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</cites><orcidid>0000-0003-2145-0863 ; 0000-0003-1388-7088</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjne.12809$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjne.12809$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31715031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Domínguez‐Ordóñez, Raymundo</creatorcontrib><creatorcontrib>García‐Juárez, Marcos</creatorcontrib><creatorcontrib>Lima‐Hernández, Francisco J.</creatorcontrib><creatorcontrib>Gómora‐Arrati, Porfirio</creatorcontrib><creatorcontrib>Domínguez‐Salazar, Emilio</creatorcontrib><creatorcontrib>Luna‐Hernández, Ailyn</creatorcontrib><creatorcontrib>Hoffman, Kurt L.</creatorcontrib><creatorcontrib>Blaustein, Jeffrey D.</creatorcontrib><creatorcontrib>Etgen, Anne M.</creatorcontrib><creatorcontrib>González‐Flores, Oscar</creatorcontrib><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><title>Journal of neuroendocrinology</title><addtitle>J Neuroendocrinol</addtitle><description>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</description><subject>Animals</subject><subject>Carbazoles - pharmacology</subject><subject>Cyclic AMP - analogs &amp; derivatives</subject><subject>Cyclic AMP - pharmacology</subject><subject>Estradiol - physiology</subject><subject>Estrogen Antagonists - pharmacology</subject><subject>Female</subject><subject>Flavonoids - pharmacology</subject><subject>Hypothalamus (ventromedial)</subject><subject>Infusions, Intraventricular</subject><subject>Kinases</subject><subject>Latency</subject><subject>Lordosis - chemically induced</subject><subject>Lordosis - physiopathology</subject><subject>lordosis behaviour</subject><subject>Male</subject><subject>MAP kinase</subject><subject>Microinjections</subject><subject>mitogen‐activated protein kinase</subject><subject>oestradiol</subject><subject>Protein kinase A</subject><subject>Protein kinase G</subject><subject>protein kinase inhibitor</subject><subject>Protein kinase inhibitors</subject><subject>Protein Kinase Inhibitors - administration &amp; dosage</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Proteins</subject><subject>Pyrimidines - pharmacology</subject><subject>Rats</subject><subject>Src protein</subject><subject>Src tyrosine kinase</subject><subject>Thionucleotides - pharmacology</subject><subject>Ventromedial Hypothalamic Nucleus - drug effects</subject><subject>Ventromedial Hypothalamic Nucleus - physiology</subject><issn>0953-8194</issn><issn>1365-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOxCAUhonR6HhZ-AKGxJWLKpTSlqUxXmPUhfuGgUPKyJQRqKYP4vuKjrqTxTkEvnx_8iN0SMkpzedsMcApLVsiNtCMspoXZVvWm2hGBGdFS0W1g3ZjXBBCG87INtphtKGcMDpDH0_BJ7ADfrGDjIDt0Nu5TT7EfDVjBJ13CvIN8rRqdDK4Cfvw9epx6gF___glaCsd7qeVT710cjlGPHdeveDY-5CwkwkGNWEjlXU2yWT9gL3Bzgfto81wtkLMSdp6t4-2jHQRDn72Hnq-uny-uCnuH69vL87vC8U4EwWbtyCYIJw0Zavaqqrz0LUABYyatjQ1Z0bVlYSyLoFXSnMlK60FN40WhO2h47V2FfzrmNO7hR_DkBO7kjFSNS2nVaZO1pQKPsYAplsFu5Rh6ijpvvrvcv_dd_-ZPfoxjvNcyR_5W3gGztbAu3Uw_W_q7h4u18pPVASTlA</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Domínguez‐Ordóñez, Raymundo</creator><creator>García‐Juárez, Marcos</creator><creator>Lima‐Hernández, Francisco J.</creator><creator>Gómora‐Arrati, Porfirio</creator><creator>Domínguez‐Salazar, Emilio</creator><creator>Luna‐Hernández, Ailyn</creator><creator>Hoffman, Kurt L.</creator><creator>Blaustein, Jeffrey D.</creator><creator>Etgen, Anne M.</creator><creator>González‐Flores, Oscar</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><orcidid>https://orcid.org/0000-0003-2145-0863</orcidid><orcidid>https://orcid.org/0000-0003-1388-7088</orcidid></search><sort><creationdate>201912</creationdate><title>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</title><author>Domínguez‐Ordóñez, Raymundo ; García‐Juárez, Marcos ; Lima‐Hernández, Francisco J. ; Gómora‐Arrati, Porfirio ; Domínguez‐Salazar, Emilio ; Luna‐Hernández, Ailyn ; Hoffman, Kurt L. ; Blaustein, Jeffrey D. ; Etgen, Anne M. ; González‐Flores, Oscar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-3b8e939050728c8446c84d69ece31f82f653fc64ae262e54cd5ca4dd95f7d903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Carbazoles - pharmacology</topic><topic>Cyclic AMP - analogs &amp; derivatives</topic><topic>Cyclic AMP - pharmacology</topic><topic>Estradiol - physiology</topic><topic>Estrogen Antagonists - pharmacology</topic><topic>Female</topic><topic>Flavonoids - pharmacology</topic><topic>Hypothalamus (ventromedial)</topic><topic>Infusions, Intraventricular</topic><topic>Kinases</topic><topic>Latency</topic><topic>Lordosis - chemically induced</topic><topic>Lordosis - physiopathology</topic><topic>lordosis behaviour</topic><topic>Male</topic><topic>MAP kinase</topic><topic>Microinjections</topic><topic>mitogen‐activated protein kinase</topic><topic>oestradiol</topic><topic>Protein kinase A</topic><topic>Protein kinase G</topic><topic>protein kinase inhibitor</topic><topic>Protein kinase inhibitors</topic><topic>Protein Kinase Inhibitors - administration &amp; dosage</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Proteins</topic><topic>Pyrimidines - pharmacology</topic><topic>Rats</topic><topic>Src protein</topic><topic>Src tyrosine kinase</topic><topic>Thionucleotides - pharmacology</topic><topic>Ventromedial Hypothalamic Nucleus - drug effects</topic><topic>Ventromedial Hypothalamic Nucleus - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Domínguez‐Ordóñez, Raymundo</creatorcontrib><creatorcontrib>García‐Juárez, Marcos</creatorcontrib><creatorcontrib>Lima‐Hernández, Francisco J.</creatorcontrib><creatorcontrib>Gómora‐Arrati, Porfirio</creatorcontrib><creatorcontrib>Domínguez‐Salazar, Emilio</creatorcontrib><creatorcontrib>Luna‐Hernández, Ailyn</creatorcontrib><creatorcontrib>Hoffman, Kurt L.</creatorcontrib><creatorcontrib>Blaustein, Jeffrey D.</creatorcontrib><creatorcontrib>Etgen, Anne M.</creatorcontrib><creatorcontrib>González‐Flores, Oscar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Domínguez‐Ordóñez, Raymundo</au><au>García‐Juárez, Marcos</au><au>Lima‐Hernández, Francisco J.</au><au>Gómora‐Arrati, Porfirio</au><au>Domínguez‐Salazar, Emilio</au><au>Luna‐Hernández, Ailyn</au><au>Hoffman, Kurt L.</au><au>Blaustein, Jeffrey D.</au><au>Etgen, Anne M.</au><au>González‐Flores, Oscar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol</atitle><jtitle>Journal of neuroendocrinology</jtitle><addtitle>J Neuroendocrinol</addtitle><date>2019-12</date><risdate>2019</risdate><volume>31</volume><issue>12</issue><spage>e12809</spage><epage>n/a</epage><pages>e12809-n/a</pages><issn>0953-8194</issn><eissn>1365-2826</eissn><abstract>An injection of unesterified oestradiol (E2) facilitates receptive behaviour in E2 benzoate (EB)‐primed, ovariectomised female rats when it is administered i.c.v. or systemically. The present study tested the hypothesis that inhibitors of protein kinase A (PKA), protein kinase G (PKG) or the Src/mitogen‐activated protein kinase (MAPK) complex interfere with E2 facilitation of receptive behaviour. In Experiment 1, lordosis induced by i.c.v. infusion of E2 was significantly reduced by i.c.v. administration of Rp‐cAMPS, a PKA inhibitor, KT5823, a PKG inhibitor, and PP2 and PD98059, Src and MAPK inhibitors, respectively, between 30 and 240 minutes after infusion. In Experiment 2, we determined whether the ventromedial hypothalamus (VMH) is one of the neural sites at which those intracellular pathways participate in lordosis behaviour induced by E2. Administration of each of the four protein kinase inhibitors into the VMH blocked facilitation of lordosis induced by infusion of E2 also into the VMH. These data support the hypothesis that activation of several protein kinase pathways is involved in the facilitation of lordosis by E2 in EB‐primed rats.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31715031</pmid><doi>10.1111/jne.12809</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-2145-0863</orcidid><orcidid>https://orcid.org/0000-0003-1388-7088</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0953-8194
ispartof Journal of neuroendocrinology, 2019-12, Vol.31 (12), p.e12809-n/a
issn 0953-8194
1365-2826
language eng
recordid cdi_proquest_journals_2330478514
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Animals
Carbazoles - pharmacology
Cyclic AMP - analogs & derivatives
Cyclic AMP - pharmacology
Estradiol - physiology
Estrogen Antagonists - pharmacology
Female
Flavonoids - pharmacology
Hypothalamus (ventromedial)
Infusions, Intraventricular
Kinases
Latency
Lordosis - chemically induced
Lordosis - physiopathology
lordosis behaviour
Male
MAP kinase
Microinjections
mitogen‐activated protein kinase
oestradiol
Protein kinase A
Protein kinase G
protein kinase inhibitor
Protein kinase inhibitors
Protein Kinase Inhibitors - administration & dosage
Protein Kinase Inhibitors - pharmacology
Proteins
Pyrimidines - pharmacology
Rats
Src protein
Src tyrosine kinase
Thionucleotides - pharmacology
Ventromedial Hypothalamic Nucleus - drug effects
Ventromedial Hypothalamic Nucleus - physiology
title Protein kinase inhibitors infused intraventricularly or into the ventromedial hypothalamus block short latency facilitation of lordosis by oestradiol
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protein%20kinase%20inhibitors%20infused%20intraventricularly%20or%20into%20the%20ventromedial%20hypothalamus%20block%20short%20latency%20facilitation%20of%20lordosis%20by%20oestradiol&rft.jtitle=Journal%20of%20neuroendocrinology&rft.au=Dom%C3%ADnguez%E2%80%90Ord%C3%B3%C3%B1ez,%20Raymundo&rft.date=2019-12&rft.volume=31&rft.issue=12&rft.spage=e12809&rft.epage=n/a&rft.pages=e12809-n/a&rft.issn=0953-8194&rft.eissn=1365-2826&rft_id=info:doi/10.1111/jne.12809&rft_dat=%3Cproquest_cross%3E2330478514%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2330478514&rft_id=info:pmid/31715031&rfr_iscdi=true